The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03020485

Enrollment

Registered

2017-01-13

Start date

2014-12-31

Completion date

2016-09-30

Last updated

2017-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The objective of this study is to determine the glycaemic effect of isomaltulose and sucrose in Chinese, Indian, Malay, and Caucasian individuals. The current study will provide important information on the potential health benefits of isomaltulose consumption in Asian population. It will also reveal how the three main ethnicities in Singapore respond to isomaltulose and whether the response differs from the Caucasians.

Detailed description

The objective of the present study is to investigate the glycaemic effect of isomaltulose in Chinese, Indians, Malays and Caucasians. This will be a single intervention. Up to fifty participants, consisting of at least ten Chinese, ten Malays, ten Indians, and ten Caucasians completed data sets, aged between 21 and 40 years will be recruited from the general public in Singapore. Participants will be asked to attend two test sessions for this study. Participants will consume either a sucrose drink or an isomaltulose drink (each containing 50 g of available carbohydrate).

Interventions

OTHERIsomaltulose

Isomaltulose is a disaccharide made up of one molecule glucose and fructose with a (α1-6) linkage.

OTHERSucrose

Sucrose is normal table sugar

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

21 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Chinese, Indian, Malay or Caucasian ethnic origin

Exclusion criteria

* People with major chronic disease such as heart disease, cancer or diabetes mellitus * Individuals with food intolerances or allergies to isomaltulose or sucrose * Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution * People with a major medical or surgical event requiring hospitalization within the preceding 3 months * Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients * Pregnant women

Design outcomes

Primary

Measure	Time frame	Description
Change in post prandial Blood glucose for 180 minutes period	180 minutes	Blood glucose obtained through finger pricks using Hemocue Glucose Analyser

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026